Fibromuscular dysplasia: Difference between revisions
No edit summary |
|||
Line 4: | Line 4: | ||
'''For patient information page, click [[{{PAGENAME}} (patient information)|here]] | '''For patient information page, click [[{{PAGENAME}} (patient information)|here]] | ||
{{CMG}}; '''Associate Editor-in-Chief:''' | {{CMG}}; '''Associate Editor-in-Chief:''' {{M.B}} | ||
'''''Synonyms and keywords:''''' FMD | '''''Synonyms and keywords:''''' FMD |
Revision as of 14:46, 9 May 2018
Fibromuscular dysplasia Microchapters |
Diagnosis |
---|
Treatment |
ASA/ACCF/AHA Guideline Recommendations |
Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries |
Case Studies |
Fibromuscular dysplasia On the Web |
American Roentgen Ray Society Images of Fibromuscular dysplasia |
Risk calculators and risk factors for Fibromuscular dysplasia |
For patient information page, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-in-Chief: Mohsen Basiri M.D.
Synonyms and keywords: FMD
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Fibromuscular dysplasia from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Arteriography | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Management Guidelines | Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies